KRISTEN MAGNER: Open Payments
NPI 1255955530 · SHELTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,303 in 110 payments from 18 companies in 2025. Trend: 2023 $2,801 · 2024 $2,943 · 2025 $2,303
Food & beverage: $2,303
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $408 |
| ABBVIE INC. | 19 | $348 |
| Lilly USA, LLC | 10 | $227 |
| Amgen Inc. | 8 | $196 |
| Esperion Therapeutics, Inc. | 7 | $175 |
| Exact Sciences Corporation | 7 | $150 |
| Novo Nordisk Inc | 5 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $129 |
| Lundbeck LLC | 6 | $126 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $120 |
Products named: JARDIANCE, VRAYLAR, BREZTRI, EVENITY, NEXLETOL, REXULTI, Cologuard Collection Kit, FARXIGA.
Industry payments across CT — which companies pay providers there.
